Benralizumab is effective in severe asthma with CRS, regardless of demographic and clinical basal outcomes. - Perez DB; Valverde-Monge M; Rosado A; Gandolfo-Cano M; Echarren TR; Moro-Moro MDM; Martos MDMR; Pineda-Pineda R; Antolin-Amérigo D; Torrado I; de la Torre MV; Cardenas R; et al. (Allergologia et immunopathologia, 2026)